Equity Analysis

Quarterly Results

    Windlas Biotech Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    543329
    INE0H5O01029
    225.6263821
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    WINDLAS
    32.88
    2011.55
    EPS(TTM)
    Face Value()
    Div & Yield %:
    29.27
    5
    0.57
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales187.00175.15171.29
Other Operating Income0.000.000.00
Other Income 4.844.134.44
Total Income191.84179.29175.73
Total Expenditure 163.95154.27149.35
PBIDT27.8925.0126.38
Interest 1.100.490.28
PBDT26.7924.5226.10
Depreciation6.506.213.54
Tax5.134.614.52
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.500.221.09
Reported Profit After Tax15.6613.4816.95
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item15.6613.4816.95
EPS (Unit Curr.)7.496.478.15
EPS (Adj) (Unit Curr.)7.496.478.15
Calculated EPS (Unit Curr.)7.496.458.15
Calculated EPS (Adj) (Unit Curr.)7.496.458.15
Calculated EPS (Ann.) (Unit Curr.)29.9725.8032.60
Calculated EPS (Adj) (Ann.) (Unit Curr.)29.9725.8032.60
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.4510.4510.40
Reserve & Surplus0.000.000.00
Face Value5.005.005.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)14.9114.2815.40
PBDTM(%)14.3314.0015.24
PATM(%)8.377.709.90
Dividend Per Share(Rs)0.000.000.00
Diluted EPS7.436.448.12